MedPath

Sun Safety Ink! A Sun Safety Program for the Tattoo Community

Not Applicable
Completed
Conditions
Skin Cancer
Interventions
Behavioral: Attention Control
Behavioral: Sun Safety Ink! Program
Registration Number
NCT03096548
Lead Sponsor
Klein Buendel, Inc.
Brief Summary

Over 3.5 million cases of non-melanoma skin cancers occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system. Klein Buendel, Inc. (KB) proposes to develop Sun Safety INK! (SSI!), a skin cancer prevention program targeted to clients of licensed tattoo studios because tattoo aftercare recommendations can include sun protection for tattoos, and studios offer an opportunity to reach younger adults who are significantly more likely to sunburn and less likely to practice sun safety. The study will assess the effectiveness of SSI! at (1) increasing full-body comprehensive sun protection practices; (2) decreasing sun burning and tanning; and, (3) decreasing positive attitudes regarding tanning and tanning attractiveness.

Detailed Description

Skin cancer prevention is a public health priority. Over 3.5 million cases of non-melanoma skin cancers (NMSC) occur annually and melanoma rates have doubled in the last 30 years, burdening the nation's health system. Increasing evidence points to the need for prevention programs to be targeted to young adults as invasive melanoma of the skin is the third most common cancer among adolescents and young adults (ages 15-39) in the U.S. Skin cancer is preventable as excess exposure to ultraviolet radiation (UVR), the primary risk factor, is modifiable and a number of public health campaigns have been developed to increase awareness about skin cancer risk and to promote sun safety. Despite these efforts, skin cancer rates continue to rise. Many adults still forget to apply sunscreen, do not pre-apply prior to sun exposure, fail to reapply, do not use clothing or wide-brimmed hats that physically block UVR and do not use shade. 4.2% of US adults engage in indoor tanning. It is well established that continued efforts are needed to promote skin cancer prevention. Concurrently, approximately, 25% of American adults have a tattoo with younger adults more likely to have tattoos than older adults. The popularity of tattoos continues to grow in the general population and particularly among members of the military. Individuals with tattoos need to take extra precaution when exposed to the sun not only to protect themselves from harmful UVR rays but also to reduce damage to their tattoos. Klein Buendel, Inc. (KB) proposes to develop and test Sun Safety INK (SSI), a skin cancer prevention program targeted to clients of licensed tattoo studios. The studios have been selected as the venue for this study because tattoo salons, at times, promote sun protection for new tattoos to keep them from fading, and offer a unique opportunity to reach younger adults who have high sunburn rates and are often less likely to practice sun protection. The studios provide a unique and compatible environment for sun safety promotion. Further, a number of successful programs have promoted health practices through similar venues such as beauty parlors and barber shops. Exploratory research with the tattoo community determined that: (1) tattoo studios were receptive to a skin cancer prevention program; (2) tattooed individuals had high rates of sunburns and low rates of sun protection but were open to receiving sun safety information and (3) a prototype SSI! program confirmed feasibility for recruitment and implementation. Based on these results, KB proposes to fully develop SSI! to include an online sun safety training for artists, a website, and additional sun safety education materials (e.g., social media). KB will work with the Alliance of Professional Tattoo Artists and the National Tattoo Association to recruit 30 licensed studios to participate in a group-randomized pair-matched pretest-posttest controlled quasi-experimental design. The primary outcomes of the study will be to evaluate the effectiveness of SSI! at: (1) increasing full-body comprehensive sun protection practices; (2) decreasing sun burning and tanning; and, (3) decreasing positive attitudes regarding tanning and tanning attractiveness.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1820
Inclusion Criteria
  • Must be 18 years of age or older
  • Must have received a tattoo in a licensed tattoo studio
Exclusion Criteria
  • Under 18 years of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Attention ControlAttention ControlThe attention control group will provide standard tattoo aftercare instructions to their clients.
Sun Safety Ink! ProgramSun Safety Ink! ProgramA program to (1) increase full-body sun comprehensive sun protection practices, (2) decrease sunburning and tanning and (3) decrease positive attitudes regarding tanning and tanning attractiveness of tattoo studio clients. The program is comprised of a video based communication strategy training presented by research staff to artists of tattoo studios.
Primary Outcome Measures
NameTimeMethod
Change in Number of SunburnsBaseline, 1 Month Posttest, 6 Month Posttest

Participants will report number of sunburns in the past 12 months.

Change in Sun Protection by Client (online survey)Baseline, 1 Month Posttest, 6 Month Posttest

Sun protection practices (sunscreen application/reapplication and Sun Protection Factor (SPF); use of lip balm, hats, protective clothing, sunglasses, shade) of tattooed and non-tattooed skin will be assessed in an online survey.

Secondary Outcome Measures
NameTimeMethod
Change in Tanning Behaviors (online survey)Baseline, 1 Month Posttest, 6 Month Posttest

Participants will complete an online survey that focuses on tanning frequency for both indoor and outdoor tanning.

Change in Tanning Attitudes (online survey)Baseline, 1 Month Posttest, 6 Month Posttest

Participants will complete an online survey that focuses on a six-item tanning image scale (1= strongly agree to 5= strongly disagree).

Trial Locations

Locations (2)

University of Colorado Denver

🇺🇸

Aurora, Colorado, United States

Klein Buendel, Inc.

🇺🇸

Golden, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath